RESEARCH ARTICLE


Pelvic Floor Muscle Training for Stress Urinary Incontinence, with and without Biofeedback: A Systematic Review and Meta-analysis of Randomized Controlled Trials



Kevin Leonardo1, *, Farhan Haidar Fazlur Rahman2, Radhyaksa Ardaya3
1 Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
3 School of Surgical and Interventional Science, University College London, London, United Kingdom


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 136
Abstract HTML Views: 149
PDF Downloads: 93
Total Views/Downloads: 400
Unique Statistics:

Full-Text HTML Views: 107
Abstract HTML Views: 53
PDF Downloads: 77
Total Views/Downloads: 255



Creative Commons License
© 2022 Leonardo et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia; Tel: +6287878418093; E-mail: kevinleonardosoputro@gmail.com


Abstract

Background:

Pelvic floor muscle training (PFMT) with biofeedback is used widely in treating patients with stress urinary incontinence (SUI), despite unclear evidence. We conducted a meta-analysis of the literature to evaluate the efficacy of treatment after PFMT with and without biofeedback in SUI patients.

Methods:

We searched PubMed, CENTRAL, CINAHL, and Science Direct for randomized controlled trials (RCTs) of PFMT with and without biofeedback for SUI. RCTs were screened with our eligibility criteria, and the risk of bias was assessed according to the Cochrane risk of bias tool for randomized trials. The outcomes analyzed were pelvic floor muscle (PFM) strength, incontinence episode, daytime micturition, and nighttime micturition, all measured as mean difference (MD) with 95% confidence intervals (CIs). Heterogeneity and publication bias were analyzed using the I2 test and a funnel plot, respectively.

Results and Discussion:

Pooled analysis of five RCTs involving 207 patients showed that the difference in PFM strength and nighttime micturition between both groups was significant. Although PFM strength improvement favors biofeedback-assisted pelvic floor muscle training (BPFMT) (MD 12.29, 95% CI 2.33, 22.25, p=0.02), in contrast, nighttime micturition was significantly reduced in the PFMT group (MD 0.44, 95% CI 0.12 to 0.77, p=0.007). Differences in incontinence episode and daytime micturition were not significant (MD -0.08, 95% CI -0.57 to 0.41, p=0.75 and MD 0.55, 95% CI -0.36 to 1.46, p=0.24, respectively).

Conclusion:

This meta-analysis showed that BPFMT had a better outcome in improving PFM strength, while nighttime micturition was, on the contrary, better in PFMT only. Meanwhile, no significant differences in incontinence episodes and daytime micturition outcomes were noted between both groups. With the present evidence, routine use of BPFMT is not necessary for current clinical practice.

Keywords: Urinary incontinence, Stress, Biofeedback, Pelvic floor muscle training, RCTs, Patients.



1. INTRODUCTION

Urinary incontinence has a global prevalence of 8.7% worldwide [1]. It is more common in women, experienced by 10% - 20% of all women and 77% of older women inhabiting nursing homes [2-7]. Despite the high prevalence, only about a quarter of women with urinary incontinence seek medical care, with only half of them eventually receiving treatment [8].

Stress urinary incontinence (SUI) is the most common etiology of urinary incontinence, defined as the involuntary loss of urine during physical activity that increases abdominal pressure. Stress urinary incontinence occurs when there is a failure of the urinary sphincter to withstand the pressure inside the bladder or failure of support of the lower urinary tract (bladder neck and urethra), resulting in urethral hypermobility. Both could happen concurrently, usually resulting from neurological disease, trauma, previous surgery, or in ageing women [9]. Physicians are required to explore risk factors including age, obstetric history, gynecological status, previous illnesses, daily activities, and pharmacological status in patients with urinary incontinence.

The treatment of SUI may include both non-surgical and surgical methods. Surgical therapy is typically utilized in patients who have failed non-surgical treatment, have moderate or severe SUI, poor quality of life, or have pelvic organ prolapse [10]. Traditional open surgery or minimally invasive surgery (laparoscopic) approach of Burch colposuspension, mid-urethral synthetic slings such as tension-free vaginal tape (TVT), trans obturator tape (TOT), and urethral bulking agents are among the procedures available [10-12]. Sling surgery is considered to be the current gold standard for treating SUI [10]. Lately, SUI treatment using stem cell therapy has a promising potential to improve the mechanism of urethral sphincter insufficiency, but further studies are needed in order to clarify the role of cell-based therapies for the treatment of SUI patients [13, 14]. The type of intervention should be tailored to the patient's symptoms, level of discomfort, goals and expectations, as well as the risks and benefits [12].

Patients more often choose conservative treatments rather than more invasive ones [15]. Pelvic floor muscle training (PFMT) is indicated for women with stress urinary incontinence, with less efficacy for urgency incontinence [16]. Aiming to improve pelvic floor muscle function, PFMT includes various exercises directed toward maximizing functional capabilities, including Kegels. Arnold Kegel first utilized Kegels to enhance the strength of floor muscles in 1940, and it is still widely used [17, 18]. Exercise may be done supervised or at home, with the latter currently emerging as it is more cost-effective [19]. Physicians use several ways to assist patients while exercising with electrostimulation, biofeedback (BF), and vaginal cones. Biofeedback is the most commonly used monitoring method for PFMT, with some studies showing no benefit from using BF augments [19-23]. Thus, the effectiveness of these adjunctive modalities remains unclear.

This study aims to systematically review and quantitatively analyze selected randomized controlled trials that evaluate PFMT and biofeedback-assisted pelvic floor muscle training (BPFMT) for patients with stress urinary incontinence.

2. MATERIALS AND METHODS

2.1. Study Methods

An extensive literature search was conducted through online databases, such as CINAHL, CENTRAL (Cochrane Library), MEDLINE (PubMed), and EMBASE (Science Direct) up to November 2021. Literature search process was carried out using medical subject headings (MeSH) terms of “stress urinary incontinence”, “pelvic floor muscle strength”, and “biofeedback”, and according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines. The literature search and selection process were performed independently by all authors involved.

2.2. Eligibility Criteria

Study literature was included only if it met the following criteria: RCT studies available in full text studies evaluating women with stress urinary incontinence who received BPFMT compared with PFMT only. Meanwhile, the exclusion criteria were inaccessible, with full text and irrelevant outcomes. The evaluated outcomes should include one of the following parameters: perineometry, incontinence episodes, daytime micturition, and nighttime micturition.

2.3. Data Collection and Statistical Analysis

Study inclusions were based on our eligibility criteria. Included studies were then examined by using the EndNote application for possible study duplication. Included studies were also assessed using the Cochrane Risk Index of Bias tool to determine the study quality. I2 test was performed to evaluate the heterogeneity of the study. If the I2 test result showed more than 50%, the heterogeneity was considered significant. On that occasion, a random-effects model would be selected for the analysis. Otherwise, if the I2 test result is valued at less than 50%, a fixed-effect model would be selected. We considered the analysis as statistically significant if the p-value was less than 0.05. All quantitative analysis was performed using Review Manager 5.4 software by Cochrane, Oxford, United Kingdom.

3. RESULTS

Summarization of the article selection process (Fig. 1) was conducted based on PRISMA guidelines. Initial database searching resulted in 1361 studies, and all were assessed using the EndNote application for study duplication. According to our inclusion criteria, the remaining 571 studies were then assessed manually by all authors. As many as thirteen articles were further analyzed for eligibility, resulting in five articles finally being analyzed qualitatively and quantitatively [24-28]. The outcomes analyzed in this study were: change of pelvic muscle floor (PFM) strength, incontinence episode, daytime micturition, and nighttime micturition. All data were pooled as mean difference (MD) since all of them were continuous data.

3.1. Study Characteristics

The analyzed studies were conducted in 4 different countries, two from Brazil, and the remaining three were from Germany, Japan, and Turkey (Table 1). A total of 96 patients received biofeedback as an adjuvant to PFMT, and 111 patients received PFMT alone. The duration of the intervention varied from 4 weeks to 12 weeks. When reported, the studies used different biofeedback methods and instruments.

Fig. (1). PRISMA flow chart.

Table 1. Study characteristics and outcome.
Study Authors Year Country Design Sample Size Age BMI (kg/m2) Training
Period
Outcome BF Method
BPFMT PFMT Only
Pages, et al. 2001 Germany RCT 13 27 51.1 N/A 4 weeks Perineometry, daytime micturition, nighttime micturition, incontinence episode Supine, intravaginal + sensor using Gemini 2000TM apparatus. Five times per week for 4 weeks, each for 15 minutes.
Aksac, et al. 2003 Japan RCT 20 20 52.5 N/A 8 weeks Perineometry, incontinence episode,
1 hour pad test, VAS, PFM strength from digital palpation
Lithotomy, intravaginal + sensor using Myomed-932. Three times per week for 8 weeks, each for 20 minutes.
Schmidt, et al. 2009 Brazil RCT 10 11 53.3 30.3 12 weeks Perineometry, daytime micturition, nighttime micturition, KHQ questionnaire Supine, intravaginal + sensor using device developed by the researcher team. First 12 weeks appointment were conducted at the hospital with evaluation after further 12 weeks at home without biofeedback
Hirakawa, et al. 2013 Turkey RCT 23 23 56.8 23.2 12 weeks Perineometry, incontinence episode,
1 hour pad test, KHQ and ICIQ-SF questionnaire
Position was not stated, intravaginal + sensor. Initial training at the hospital using FemiScan Clinic System, followed with further 12 weeks of training twice a day each for 8 minutes using FemiScan Home Trainer
Fitz, et al. 2017 Brazil RCT 30 30 56.3 29 12 weeks Perineometry, incontinence episode, oxford scale Supine for the 1st month, sitting for the 2nd month, standing for the 3rd month. intravaginal + sensor using Neurodyn Evolution pressure biofeedback. Twice a week for the first 3 months, each 40 minutes. Followed with further training at home for 6 months.
Abbreviation: BF: Biofeedback; BMI: Body mass index; BPFMT: Biofeedback-assisted pelvic floor muscle training; ICIQ-SF: International consultation on incontinence questionnaire – short form; Kg: Kilogram KHQ: King’s health questionnaire; m: meter; PFM: Pelvic floor muscle; PFMT: Pelvic floor muscle training; RCT: Randomized controlled trial; VAS: Visual analog scale.
Fig. (2). Forest plot of comparative effect between biofeedback PFMT and PFMT only on pelvic muscle floor strength, measured by perineometry (cm H20).
SD, standard deviation; IV, inverse variance; CI, confidence interval.

Fig. (3). Forest plot of comparative effect between biofeedback PFMT and PFMT only on incontinence episodes.
SD, standard deviation; IV, inverse variance; CI, confidence interval.

3.2. Pelvic Muscle Strength Comparison

Five studies evaluating 207 participants were included in the pooled analysis for pelvic muscle strength between both groups. Significant heterogeneity was found in this analysis (I2=93%), so a random-effect model of the analysis was used. Pooled analysis in Fig. (2) showed that there was significant PFM strength improvement in the group receiving BPFMT compared to PFMT only (MD 12.29, 95% CI 2.33 to 22.25, p=0.02)

3.3. Incontinence Episode Comparison

Three studies, including 146 subjects allocated into the BPFMT (n=73) and PFMT only (n=73) groups, described the number of incontinences experienced. Pooled analysis presented in Fig. (3) showed no significant difference between both treatment groups in terms of incontinence episodes that occurred (MD -0.08, 95% CI -0.57 to 0.41, p=0.75). A random-effects model was again selected for the calculation due to significant heterogeneity.

3.4. Daytime Micturition Comparison

Two studies with 61 women from both BPFMT (n=23) and PFMT only (n=38) groups reported daytime micturition frequency differences before and after treatment. Pooled analysis showed no significant difference between both groups (MD 0.55, 95% CI -0.36 to 1.46, p=0.24). Fig. (4) showed that the fixed-effect model was selected because no significant heterogeneity was found among the studies (I2=41%).

3.5. Nighttime Micturition Comparison

As well as the daytime micturition comparison, two studies involving 61 participants were also included for the nighttime micturition comparison before and after the treatment (23 from the BPFMT group and 38 from the PFMT group). Pooled MD values (Fig. 5) were estimated using a fixed-effects model of calculation since there was no significant heterogeneity among those two trials (I2=0%), resulting in a significant difference in nighttime micturition reduction, which favored the PFMT group (MD 0.44, 95% CI 0.12 to 0.77, p= 0.007).

4. DISCUSSION

In this meta-analysis, higher pelvic muscle strength was shown in patients undergoing BPFMT when compared to PFMT without BF group. In contrast, PFMT only group was associated with improved nighttime micturition. No significant difference was found in incontinence episodes and daytime micturition. These findings contradict the classical belief that stronger pelvic muscle is associated with better incontinence manifestations.

Despite various studies that have been undertaken to address the issue, there is little consensus on the effectiveness of PFMT over BPFMT. Pages et al. [24], Aksac et al. [25] and Schmidt et al. [26] found that the BPFMT group had much higher changes in PFM strength than the PFMT alone group. Some studies, such as Hirakawa et al. [27] and Fitz et al. [28], found no significant difference in PFM strength change in patients between the two groups.

Schmidt et al. [26] hypothesized that BPFMT would develop pelvic muscle floor strength even more because the patient can adjust or improve the training by seeing the intensity and contraction waveform as visual feedback. Another study by Mørkved et al. [29] found that using equipment during training could motivate many women and that it should be considered as a treatment option. Adding biofeedback to pelvic floor muscle training supports pelvic floor exercise, according to Berghmans et al. [30], it is most significant at the beginning of the therapy period. This may justify a considerable improvement in PFM function by boosting exercise performance and treatment motivation and as an easier guide for the patient to learn the exercises correctly [28].

PFM strength improvement following BPFMT or PFMT will consequently increase urethral sphincter strength [31]. The decrease in incontinence episodes and micturition frequency, either daytime or nighttime, are expected from the consequent increase of urethral sphincter strength [32]. Although BPFMT is associated with better PFM strength, in this meta-analysis BPFMT group does not manifest better outcomes in incontinence episodes, daytime micturition, and nighttime micturition.

In comparison to PFMT, Fitz et al. [28] found that BPFMT is related to improved incontinence episodes. However, investigations by Aksac et al. [25] and Hirakawa et al. [27] found that the BPFMT group had similar episodes of incontinence and daytime micturition to the PFMT group. These results are consistent with the findings of this review, which found no significant difference in incontinence episodes or daytime micturition between the BPFMT and PFMT alone groups.

Fig. (4). Forest plot of comparative effect between biofeedback PFMT and PFMT only on daytime micturition.
SD, standard deviation; IV, inverse variance; CI, confidence interval

Fig. (5). Forest plot of comparative effect between biofeedback PFMT and PFMT only on nighttime micturition.
SD, standard deviation; IV, inverse variance; CI, confidence interval.

We discovered that BF has some advantages of its own, particularly in terms of pelvic muscle strength and function. Through audio-visual feedback, the BF supports patients in isolating and training the right muscle groups, which can be difficult to do without assistance [24]. Biofeedback may be a viable option, particularly for women with low or absent PFM strength or who are unaware of voluntary pelvic floor muscle contraction [27]. Although the use of devices may increase treatment costs; biofeedback provides the patient with an instrument to correctly conduct pelvic floor muscle workouts. Patients with more complicated disease presentations will likely benefit more from the additional information that biofeedback provides.

In summary, the results of all studies revealed heterogeneity in terms of BPFMT's efficacy as a treatment of choice for improving PFM strength. Unfortunately, full-text versions of some literature were not available during the research. Second, there was a scarcity of data on daytime and nighttime micturition. Evaluation variables, such as satisfaction rate, changes in quality of life, and events of recurrence incontinence should be considered in future research on the topic, as these are important clinical features to evaluate once the therapy is completed.

CONCLUSION

PFMT alone offers a reliable noninvasive exercise in improving incontinence symptoms with current evidence. Despite the significant PFM strength improvement associated with BPFMT, similar incontinence episodes were observed in BPFMT and PFMT. With periodical monitoring by healthcare professionals, PFMT may be done at home to increase cost-effectiveness and the number of hospital visits required throughout the exercise regimen.

LIST OF ABBREVIATIONS

BF = Biofeedback
BMI = Body Mass Index
BPFMT = Biofeedback-assisted Pelvic Floor Muscle Training
CI = Confidence Interval
ICIQ-SF = International Consultation On Incontinence Questionnaire – Short Form
IV = Inverse Variance
Kg = kilogram
KHQ = King’s Health Questionnaire
m = Meter
MD = Mean Difference
MeSH = Medical Subject Headings
PFM = Pelvic Floor Muscle
PFMT = Pelvic Floor Muscle Training
PRISMA = Preferred Reporting Items For Systematic Reviews And Meta-analysis
RCT = Randomized Controlled Trial
RR = Risk Ratio
SUI = Stress Urinary Incontinence
VAS = Visual Analog Scale

AUTHORS’ CONTRIBUTIONS

Study concept and design: Kevin Leonardo, Farhan Haidar Fazlur Rahman, Radhyaksa Ardaya; Data acquisition: Kevin Leonardo, Farhan Haidar Fazlur Rahman, Radhyaksa Ardaya; Data analysis: Kevin Leonardo, Farhan Haidar Fazlur Rahman, Radhyaksa Ardaya; Drafting of the manuscript: Kevin Leonardo, Farhan Haidar Fazlur Rahman; Critical revision of the manuscript: Kevin Leonardo, Radhyaksa Ardaya

CONSENT FOR PUBLICATION

Not applicable.

STANDARDS OF REPORTING

PRISMA guidelines were followed.

AVAILABILITY OF DATA AND MATERIALS

The data that support the findings of this study are openly available in the:

• American Journal of Physical Medicine and Rehabilitation at https://doi.org/10.1097/00002060-200107000-00006, reference number [19],

• Gynecologic and Obstetric Investigation at https://doi.org/10.1159/000072327, reference number [20],

• International Journal of Gynaecology and Obstetrics at https://doi.org/10.1016/j.ijgo.2009.01.013, reference number [21],

• International Urogynecology Journal at https://doi.org/10.1007/s00192-012-2012-8 and https://doi.org/10.1007/s00192-012-1707-1 reference number [22, 23].

FUNDING

None.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

FUNDING

None.

ACKNOWLEDGEMENTS

The authors thank Florentina Priscilla and Meutia Putri Aristya for their help in the preparation of this manuscript.

SUPPLEMENTARY MATERIAL

PRISMA checklist is available as supplementary material onthe publisher’s website along with the published article.


REFERENCES

[1] Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006; 50(6): 1306-15.
[2] Anger JT, Saigal CS, Litwin MS. The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol 2006; 175(2): 601-4.
[3] Lawrence JM, Lukacz ES, Nager CW, Hsu JWY, Luber KM. Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol 2008; 111(3): 678-85.
[4] Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008; 300(11): 1311-6.
[5] Offermans MPW, Du Moulin MFMT, Hamers JPH, Dassen T, Halfens RJG. Prevalence of urinary incontinence and associated risk factors in nursing home residents: A systematic review. Neurourol Urodyn 2009; 28(4): 288-94.
[6] Tennstedt SL, Link CL, Steers WD, McKinlay JB. Prevalence of and risk factors for urine leakage in a racially and ethnically diverse population of adults: the Boston Area Community Health (BACH) Survey. Am J Epidemiol 2008; 167(4): 390-9.
[7] Wu JM, Vaughan CP, Goode PS, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol 2014; 123(1): 141-8.
[8] Minassian VA, Yan X, Lichtenfeld MJ, Sun H, Stewart WF. The iceberg of health care utilization in women with urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2012; 23(8): 1087-93.
[9] Kim Y, Kwak Y, Brubaker L, Cornu JN, Daly JO, Cartwright R. Urinary incontinence in women in relation to occupational status. Women Health 2017; 57(1): 1-18.
[10] Huang ZM, Xiao H, Ji ZG, Yan WG, Zhang YS. TVT versus TOT in the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Ther Clin Risk Manag 2018; 14: 2293-303.
[11] Harding C, Lapitan M, Arlandis S, Bø K, Costantini E, Groen J. EAU guidelines on management of non-neurogenic female lower urinary tract symptoms (LUTS) 2021.
[12] Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary incontinence: AUA/SUFU guideline. J Urol 2017; 198(4): 875-83.
[13] Aragón IM, Imbroda BH, Lara MF. Cell therapy clinical trials for stress urinary incontinence: current status and perspectives. Int J Med Sci 2018; 15(3): 195-204.
[14] Zhou S, Zhang K, Atala A, Khoury O, Murphy SV, Zhao W, et al. Stem cell therapy for treatment of stress urinary incontinence: the current status and challenges. Stem Cells International 2016; 2016
[15] Lukacz ES, Santiago-Lastra Y, Albo ME, Brubaker L. Urinary incontinence in women: a review. JAMA 2017; 318(16): 1592-604.
[16] Dumoulin C, Hay-Smith J, Habée-Séguin GM, Mercier J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: A short version Cochrane systematic review with meta-analysis. Neurourol Urodyn 2015; 34(4): 300-8.
[17] Bo K, Frawley HC, Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 2017; 28(2): 191-213.
[18] Kegel AH. Progressive resistance exercise in the functional restoration of the perineal muscles. Am J Obstet Gynecol 1948; 56(2): 238-48.
[19] Sjöström M, Umefjord G, Lindholm L, Samuelsson E. Cost‐effectiveness of an Internet‐based treatment program for stress urinary incontinence. Neurourol Urodyn 2015; 34(3): 244-50.
[20] Glazer HI, Laine CD. Pelvic floor muscle biofeedback in the treatment of urinary incontinence: a literature review. Appl Psychophysiol Biofeedback 2006; 31(3): 187-201.
[21] Herderschee R, Hay‐Smith EJC, Herbison GP, Roovers JP, Heineman MJ. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Systematic Reviews 2011.
[22] Moroni R, Magnani P, Haddad J, Castro R, Brito L. Castro RdA, Brito LGO. Conservative treatment of stress urinary incontinence: a systematic review with meta-analysis of randomized controlled trials. Rev Bras Ginecol Obstet 2016; 38(2): 097-111.
[23] Schreiner L, Santos TG, Souza ABA, Nygaard CC, Filho IGS. Electrical stimulation for urinary incontinence in women: a systematic review. Int Braz J Urol 2013; 39(4): 454-64.
[24] Pages IH, Jahr S, Schaufele MK, Conradi E. Comparative analysis of biofeedback and physical therapy for treatment of urinary stress incontinence in women. Am J Phys Med Rehabil 2001; 80(7): 494-502.
[25] Aksac B, Aki S, Karan A, Yalcin O, Isikoglu M, Eskiyurt N. Biofeedback and pelvic floor exercises for the rehabilitation of urinary stress incontinence. Gynecol Obstet Invest 2003; 56(1): 23-7.
[26] Schmidt AP, Sanches PRS, Silva DP Jr, Ramos JGL, Nohama P. A new pelvic muscle trainer for the treatment of urinary incontinence. Int J Gynaecol Obstet 2009; 105(3): 218-22.
[27] Hirakawa T, Suzuki S, Kato K, Gotoh M, Yoshikawa Y. Randomized controlled trial of pelvic floor muscle training with or without biofeedback for urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2013; 24(8): 1347-54.
[28] Fitz FF, Resende APM, Stüpp L, Sartori MGF, Girão MJBC, Castro RA. Biofeedback for the treatment of female pelvic floor muscle dysfunction: a systematic review and meta-analysis. Int Urogynecol J Pelvic Floor Dysfunct 2012; 23(11): 1495-516.
[29] Mørkved S, Bø K. Effect of pelvic floor muscle training during pregnancy and after childbirth on prevention and treatment of urinary incontinence: a systematic review. Br J Sports Med 2014; 48(4): 299-310.
[30] Berghmans B, Seleme MR, Bernards ATM. Physiotherapy assessment for female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2020; 31(5): 917-31.
[31] Chmel R, Rob L, Vlk R, et al. [Prevalence of the female urinary incontinence. Results from a questionnaire study]. Ceska Gynekol 2004; 69(4): 339-44.
[32] Alvarez J, Cvach K, Dwyer P. Complications in pelvic floor surgery. Minerva Ginecol 2013; 65(1): 53-67.